Global Glaucoma Surgery Devices Market Report and Forecast 2024-2032

Global Glaucoma Surgery Devices Market Outlook

The global glaucoma surgery devices market size was valued at USD 1.8 billion in 2023, driven by the increasing incidence of glaucoma across the globe. The market is expected to grow at a CAGR of 14.5% during the forecast period of 2024-2032, with the values likely to rise from USD 2.1 billion in 2024 to USD 6.1 billion by 2032.

Glaucoma Surgery Devices: Introduction

Glaucoma is a set of eye diseases that can cause blindness and vision loss by damaging the optic nerve. It is caused by increased intraocular pressure in your eyes. Open-angle glaucoma and angle-closure glaucoma are the two main types of glaucoma.

Lowering the intraocular pressure to reduce the complication from accelerating is the main method to treat glaucoma. It can be done through medications, eye drops, laser surgery or minimally invasive glaucoma surgeries.

Global Glaucoma Surgery Devices Market Analysis

Glaucoma is a major cause of irreversible vision loss, projected to affect around 111.8 million  people by 2040. Traditional approaches for addressing glaucoma involve medications, filtration surgery, or laser treatments, such as trabeculectomy. Nevertheless, poor tolerability and compliance are often associated with medications. Therefore, there has been an increasing preference towards using minimally invasive devices, which has fuelled the glaucoma surgery devices market demand.

Glaucoma surgery devices have observed notable progress with the introduction of innovative technologies characterized by an ab interno corneal incisional approach. These advancements emphasize offering minimal trauma, enhanced safety, and faster recovery for patients. For instance, devices like iStent Inject, feature a reduced size compared to its predecessor. It also enables the simultaneous implantation of two stents. In addition, Streamline by New World Medical and Hydrus by Alcon, are other newly introduced minimally invasive devices.

Non-penetrating glaucoma surgeries (NPGS), like deep sclerectomy and canaloplasty, have emerged as a safer and still effective way to reduce IOP in patients with more advanced glaucoma. In addition, the increasing involvement of prominent healthcare companies in ophthalmology is also driving the glaucoma surgery devices market growth. Ciliatech has announced their new class of implant called CID (Cilio-scleral Inter-positioning Device) to help reduce the IOP without entering the eye’s anterior chamber.

Global Glaucoma Surgery Devices Market Segmentation

Market Breakup by Surgery Type

• Conventional Glaucoma Surgeries

• Minimally Invasive Glaucoma Surgeries

Market Breakup by Products

• Implants and Stents

• Glaucoma Drainage Devices

• Glaucoma Laser Devices

Market Breakup by End User

• Hospitals

• Surgical Centres

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Glaucoma Surgery Devices Market Overview

The increasing incidence of glaucoma has led to the development of several initiatives by government, non-profit and key healthcare companies to spread awareness on early diagnosis of the disease. In March 2023, ENTOD Eye Health Foundation launched a glaucoma awareness campaign in India. This campaign also conducted screenings in major Indian states. Such efforts are set to fuel substantial glaucoma surgery devices market value, not only in India, but the Asia Pacific region as well.

Similarly, Bausch + Lomb Corp., along with the Glaucoma Research Foundation, launched a campaign called Scree, Protect, Cure in the United States. This initiative can be considered highly important as the United States has been hugely affected by the illness in the historic period. We can also expect the region to lead the glaucoma surgery devices market share as it has a robust healthcare system and is home to several healthcare companies.

We can also anticipate Europe to experience noteworthy growth during the forecast period. This can be attributed to the increasing geriatric population and the growing adoption, as well as the integration of advanced technologies into the healthcare system. The accessibility and affordability of medical facilities in the region further solidifies its standing in the market.

Global Glaucoma Surgery Devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Abbvie Inc. (Allergan)

• Alcon Inc

• Glaukos Corporation 

• Johnson & Johnson (Abbott Medical Optics) 

• iStar Medical SA 

• Lumibird Medical (Ellex Medical Lasers Ltd) 

• Lumenis Ltd 

• New World Medical, Inc. 

• Santen Pharmaceutical Co. Ltd 

• Topcon Corporation

Key Highlights of the Report